Where does Orano MED rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Orano MED ranks #36,837 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Orano MED hold?

Orano MED holds 7 US utility patents granted between 2018 and 2025, spanning 7 technology areas.

What is Orano MED's Innovation Score?

Orano MED has an Innovation Score of 35.5 out of 100 (top 49% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Orano MED focus on?

Orano MED's top technology area is G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources) with 6 patents. Grants appear in 7 CPC subclasses total.

Is Orano MED's patent grant rate increasing or decreasing?

Orano MED's recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Orano MED's patents?

Orano MED's patents average 15.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Orano MED patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Orano MED

USPTO PatentsView assignee record - 7 granted patents across 7 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Orano ranks #36,837 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 7 technology areas.

#36,837
of 49,997 US assignees by volume: Top 49%
by Innovation Score (35.5/100): 15.0
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R36837 · Foreign Corporation #36,837 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 7 grants
MID-PACK #36,837/49,997
PHOTO-FINISH Opton
CPC-NARROW G21G · 7 areas
INNOV-THIN 35.5/100
CLAIMS-RICH 15.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Opton Co. Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Orano MED · this assignee

36
3D Lighting… · lowest

7

What this shows Orano's Innovation Score is 35.5/100 (top 49% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Orano's grants concentrate

Orano MED is a focused PatentsView assignee: 7 CPC subclasses with 85.7% of grants classified under G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2018. By volume, Orano sits between Opton Co. Ltd. and Orion Engineered Carbons GMBH.

Orano's three-year grant acceleration

Orano MED shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Opton

7
Optotune Switzerl…

7
OQ Technology S á…

7
Oracle OTC Subsid…

7
Orca Health

7
Orient Chemical I…

7
Oriental Union Ch…

7
Orion Engineered…

7
Orano MED ◀

7

What this shows Orano holds 7 patents at rank #36,775, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Orano

By rank, the assignees closest to #36,775 in granted patent volume.

Leaders in G21G (Conversion OF Chemical Elements)

Other assignees with the most granted patents in Orano's primary technology class.

Orano's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 49% higher than 51% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Orano MED patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	1	14.3%
2020	1	14.3%
2021	1	14.3%
2023	1	14.3%
2024	2	28.6%
2025partial year	1	14.3%

Which technologies does Orano MED patent most?

G21G - Conversion OF Chemical ELEMENTS; Radioactive Sources 6

B01D - Separation 6

C22B - Production AND Refining OF Metals ; Pretreatment OF RAW Materials 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

C22C - Alloys 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

Top 7 of 7 technology areas

Where it ranks

Overall rank by patents

#36,837

of 49,997 tracked assignees

Innovation Score

35.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Orano MED's patent record in context - here's where to go next.

Orano MED's lead technology class is G21G (Conversion OF Chemical ELEMENTS; Radioactive Sources), 85.7% of its portfolio - see every assignee active in that class. Explore G21G
Ranked #36,837 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Orano MED against Opton Co. Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.